• Earth Science Tech is a Florida-based company with a vision of enhancing the quality of people’s lives through varied wellness initiatives as part of a growing $4.2 trillion industry
• The company’s two subsidiaries have a targeted focus on helping women who might not normally pursue health care to assess and treat STIs, as well as on utilizing hemp derivatives as therapy for a variety of maladies
• ETST also supports a favored entity’s efforts to gain non-profit status for accepting grants that would further CBD studies and assist the company in donating its products on the basis of need

The health and wellness industry continues to accelerate annual sales of products and philosophies designed to help people live life and love it, propelled in large part by concerns about the rising costs of health care and the decrease in age of patients reporting select chronic ailments, including heart disease. The Global Wellness Institute reports that wellness industry revenues increased by 6.4 percent annually from 2015-17 to become a $4.2 trillion market that is growing nearly twice as fast as the global economy (http://ibn.fm/afG7j).

Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) has built a variety of partnerships that support its two wholly owned subsidiaries, as well as a favored non-profit entity, in their endeavors to advance consumers’ wellbeing. The company’s mission is focused on cannabis/industrial hemp and medical devices.

Subsidiary Earth Science Pharmaceutical is committed to bringing low-cost, non-invasive testing processes and vaccines for sexually transmitted infections to market to help women improve the quality of their lives. The company’s first medical device, Hygee, is a home kit designed as a modified panty liner to allow for the self-collection of a gynecological specimen that can be tested for two types of infections – chlamydia and gonorrhea. It gives women the ability to self-collect specimens in a non-clinical setting before sending them to a laboratory that will process the specimens and notify them if they test positive so that they can seek treatment.

The motivation behind the technology is to help women and girls in high-risk situations, who might not be willing or able to seek out assistance through traditional medical care facilities, take responsible action for their own wellbeing with the help of online ordering and home screening.

ETST’s second subsidiary, Cannabis Therapeutics, is investing in the medicinal power of hemp-derived cannabidiol (CBD). Earth Science Tech holds three provisional application patents for a CBD product that the company aims to use in developing treatments for breast and ovarian cancers, and for two generic pharmaceutical drugs with a CBD foundation.

Industrial hemp-based CBD and full-spectrum oils provide the company a core operation with increasing revenues, but Earth Science Tech has also been invested in research and developmental lab work that it hopes to continue for advancing varied high-quality natural hemp extracts and identifying their distinct properties. In addition to breast and ovarian cancer treatments, the company aims to further non-prescription therapies for chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea and general aging-related maladies.

ETST’s formulations are expected to include options such as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs and may include products such as CBD as a natural constituent of hemp oil, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products (http://ibn.fm/5Hokn).

As a companion entity to Earth Science Tech’s subsidiary operations, the company backs favored entity Earth Science Foundation’s effort to become a non-profit organization that can accept grants and donations to conduct further studies and assist in donating Earth Science Tech’s effective CBD products to those in need.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html